Literature DB >> 20001783

Successful treatment of pacemaker-induced stricture and thrombosis of the cranial vena cava in two dogs by use of anticoagulants and balloon venoplasty.

Suzanne M Cunningham1, Marisa K Ames, John E Rush, Elizabeth A Rozanski.   

Abstract

CASE DESCRIPTION: 2 castrated male Labrador Retrievers (dogs 1 and 2) were evaluated 3 to 4 years after placement of a permanent pacemaker. Dog 1 was evaluated because of a large volume of chylous pleural effusion. Dog 2 was admitted for elective replacement of a pacemaker. CLINICAL
FINDINGS: Dog 1 had mild facial swelling and a rapidly recurring pleural effusion. Previously detected third-degree atrioventricular block had resolved. Cranial vena cava (CVC) syndrome secondary to pacemaker-induced thrombosis and stricture of the CVC was diagnosed on the basis of results of ultrasonography, computed tomography, and venous angiography. Dog 2 had persistent third-degree atrioventricular block. Intraluminal caval stricture and thrombosis were diagnosed at the time of pacemaker replacement. Radiographic evidence of pleural effusion consistent with CVC syndrome also was detected at that time. TREATMENT AND OUTCOME: Dog 1 improved after treatment with unfractionated heparin and a local infusion of recombinant tissue-plasminogen activator. Balloon venoplasty was performed subsequently to relieve the persistent caval stricture. In dog 2, balloon dilatation of the caval stricture was necessary to allow for placement of a new pacing lead. Long-term anticoagulant treatment was initiated in both dogs. Long-term (> 6 months) resolution of clinical signs was achieved in both dogs. CLINICAL RELEVANCE: Thrombosis and stricture of the CVC are possible complications of a permanent pacemaker in dogs. Findings suggested that balloon venoplasty and anticoagulation administration with or without thrombolytic treatment can be effective in the treatment of dogs with pacemaker-induced CVC syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20001783     DOI: 10.2460/javma.235.12.1467

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  6 in total

1.  Cranial vena cava syndrome secondary to cryptococcal mediastinal granuloma in a cat.

Authors:  Jo-Annie Letendre; Søren Boysen
Journal:  Can Vet J       Date:  2015-04       Impact factor: 1.008

2.  Concurrent cranial mediastinal Blastomyces granuloma and carcinoma with cranial vena caval syndrome in a dog.

Authors:  Natashia A Evans; Katrina R Viviano
Journal:  Can Vet J       Date:  2015-11       Impact factor: 1.008

3.  Complication rates associated with transvenous pacemaker implantation in dogs with high-grade atrioventricular block performed during versus after normal business hours.

Authors:  J L Ward; T C DeFrancesco; S P Tou; C E Atkins; E H Griffith; B W Keene
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

4.  Retrospective Analysis of Indications and Complications Related to Implantation of Permanent Pacemaker: 25 Years of Experience in 31 Dogs.

Authors:  Agnieszka Noszczyk-Nowak; Marcin Michałek; Karolina Kapturska; Adrian Janiszewski; Robert Pasławski; Piotr Skrzypczak; Urszula Pasławska
Journal:  J Vet Res       Date:  2019-03-22       Impact factor: 1.744

5.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

6.  A retrospective review of 146 active and passive fixation bradycardia lead implantations in 74 dogs undergoing pacemaker implantation in a research setting of short term duration.

Authors:  Lynne E Swanson; Barbara A Huibregtse; Brian A Scansen
Journal:  BMC Vet Res       Date:  2018-03-27       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.